@article{beatovbora2014longterm,
  title = {Long-Term Survival of a Patient with Jejunal Somatostatin-Producing Tumour and Liver Metastases},
  author = {P. I. Beato-Víbora and R. Rodríguez-López and J. R. Rodríguez-Mowbray and  J. J. Fernández-Mera},
  year = 2014,
  url = {https://ibimapublishing.com/articles/IJCRM/2014/421263/},
  journal = {International Journal of Case Reports in Medicine},
  volume = 2014 (2014),
  pages = 6,
  doi = 10.5171/2014.421263,
  abstract = {Extrapancreatic somatostatinomas are uncommon neuroendocrine tumours. Information related to its long-term prognosis is scarce. The prognosis of patients with advanced somatostatinoma is expected to be poor, but some tumours show low malignant potential and long-term survival rates have been described, even in the presence of metastases. We present a case of a 30-year-old patient, diagnosed with jejunal somatostatinoma. Multiple liver metastases were present at diagnosis. The primary tumour was removed and somatostatin analogues were prescribed. The patient survived for 12 years, with acceptable quality of life, although he suffered from repeated episodes of abdominal pain, diarrhea and vomiting along with severe hyperglycaemia followed by hypoglycaemia. Finally, he died because of severe ascitis and dyspnea due to tumour progression.},
  keywords = {Neuroendocrine tumour, somatostatinoma, survival, liver metastases.},
  note = Article ID: 421263
}